Selected research
Industry Growth & Trends
Global Lyme Disease Testing Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Lyme Disease Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Lyme Disease Testing is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Lyme Disease Testing is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Lyme Disease Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Lyme Disease Testing market include Quidel Corporation, Roche Holding AG, Fujirebio(H.U. Group Holdings), ZEUS Scientific, IGeneX, Thermo Fisher Scientific, Everlywell, Oxford Immunotec Global PLC(PerkinElmer) and BioMerieux, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Lyme Disease Testing market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Lyme Disease Testing market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Lyme Disease Testing market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Lyme Disease Testing.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Lyme Disease Testing market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Lyme Disease Testing Market by Company
Quidel Corporation
Roche Holding AG
Fujirebio(H.U. Group Holdings)
ZEUS Scientific
IGeneX
Thermo Fisher Scientific
Everlywell
Oxford Immunotec Global PLC(PerkinElmer)
BioMerieux
Bio-Rad Laboratories
T2 Biosystems
Lyme Disease Testing Segment by Type
ELISA
Western Blotting
PCR
Others
Lyme Disease Testing Segment by Application
Hospital and Testing Agency
Personal
Lyme Disease Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lyme Disease Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lyme Disease Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lyme Disease Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Lyme Disease Testing companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- ELISA
- Western Blotting
- PCR
- Others
Applications
- Hospital and Testing Agency
- Personal
Companies covered
- Quidel Corporation
- Roche Holding AG
- Fujirebio(H.U. Group Holdings)
- ZEUS Scientific
- IGeneX
- Thermo Fisher Scientific
- Everlywell
- Oxford Immunotec Global PLC(PerkinElmer)
- BioMerieux
- Bio-Rad Laboratories
- T2 Biosystems
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Lyme Disease Testing Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Lyme Disease Testing Market Size by Region (2021-2032)
- 1.4.1 Global Lyme Disease Testing Market Size by Region (2021-2026)
- 1.4.2 Global Lyme Disease Testing Market Size by Region (2027-2032)
- 1.5 Key Regions Lyme Disease Testing Market Size (2021-2032)
- 1.5.1 North America Lyme Disease Testing Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Lyme Disease Testing Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Lyme Disease Testing Market Size Growth Rate (2021-2032)
- 1.5.4 South America Lyme Disease Testing Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Lyme Disease Testing Market Size Growth Rate (2021-2032)
2 Lyme Disease Testing Market by Type
- 2.1 Type Introduction
- 2.1.1 ELISA
- 2.1.2 Western Blotting
- 2.1.3 PCR
- 2.1.4 Others
- 2.2 Global Lyme Disease Testing Market Size by Type
- 2.2.1 Global Lyme Disease Testing Market Size Overview by Type (2021-2032)
- 2.2.2 Global Lyme Disease Testing Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Lyme Disease Testing Market Size Forecasted by Type (2027-2032)
- 2.3 Global Lyme Disease Testing Market Size by Regions
- 2.3.1 North America Lyme Disease Testing Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Lyme Disease Testing Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Lyme Disease Testing Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Lyme Disease Testing Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Lyme Disease Testing Market Size Breakdown by Type (2021-2026)
3 Lyme Disease Testing Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospital and Testing Agency
- 3.1.2 Personal
- 3.2 Global Lyme Disease Testing Market Size by Application
- 3.2.1 Global Lyme Disease Testing Market Size Overview by Application (2021-2032)
- 3.2.2 Global Lyme Disease Testing Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Lyme Disease Testing Market Size Forecasted by Application (2027-2032)
- 3.3 Global Lyme Disease Testing Market Size by Regions
- 3.3.1 North America Lyme Disease Testing Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Lyme Disease Testing Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Lyme Disease Testing Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Lyme Disease Testing Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Lyme Disease Testing Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Lyme Disease Testing Industry Trends
- 4.2 Lyme Disease Testing Industry Drivers
- 4.3 Lyme Disease Testing Industry Opportunities and Challenges
- 4.4 Lyme Disease Testing Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Lyme Disease Testing Revenue (2021-2026)
- 5.2 Global Lyme Disease Testing Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Lyme Disease Testing Key Company Headquarters & Area Served
- 5.4 Global Lyme Disease Testing Company, Product Type & Application
- 5.5 Global Lyme Disease Testing Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Lyme Disease Testing Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Lyme Disease Testing Players Market Share by Revenue in 2025
- 5.6.3 2025 Lyme Disease Testing Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Quidel Corporation
- 6.1.1 Quidel Corporation Company Information
- 6.1.2 Quidel Corporation Business Overview
- 6.1.3 Quidel Corporation Lyme Disease Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Quidel Corporation Lyme Disease Testing Product Portfolio
- 6.1.5 Quidel Corporation Recent Developments
- 6.2 Roche Holding AG
- 6.2.1 Roche Holding AG Company Information
- 6.2.2 Roche Holding AG Business Overview
- 6.2.3 Roche Holding AG Lyme Disease Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Roche Holding AG Lyme Disease Testing Product Portfolio
- 6.2.5 Roche Holding AG Recent Developments
- 6.3 Fujirebio(H.U. Group Holdings)
- 6.3.1 Fujirebio(H.U. Group Holdings) Company Information
- 6.3.2 Fujirebio(H.U. Group Holdings) Business Overview
- 6.3.3 Fujirebio(H.U. Group Holdings) Lyme Disease Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Fujirebio(H.U. Group Holdings) Lyme Disease Testing Product Portfolio
- 6.3.5 Fujirebio(H.U. Group Holdings) Recent Developments
- 6.4 ZEUS Scientific
- 6.4.1 ZEUS Scientific Company Information
- 6.4.2 ZEUS Scientific Business Overview
- 6.4.3 ZEUS Scientific Lyme Disease Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 ZEUS Scientific Lyme Disease Testing Product Portfolio
- 6.4.5 ZEUS Scientific Recent Developments
- 6.5 IGeneX
- 6.5.1 IGeneX Company Information
- 6.5.2 IGeneX Business Overview
- 6.5.3 IGeneX Lyme Disease Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 IGeneX Lyme Disease Testing Product Portfolio
- 6.5.5 IGeneX Recent Developments
- 6.6 Thermo Fisher Scientific
- 6.6.1 Thermo Fisher Scientific Company Information
- 6.6.2 Thermo Fisher Scientific Business Overview
- 6.6.3 Thermo Fisher Scientific Lyme Disease Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Thermo Fisher Scientific Lyme Disease Testing Product Portfolio
- 6.6.5 Thermo Fisher Scientific Recent Developments
- 6.7 Everlywell
- 6.7.1 Everlywell Company Information
- 6.7.2 Everlywell Business Overview
- 6.7.3 Everlywell Lyme Disease Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Everlywell Lyme Disease Testing Product Portfolio
- 6.7.5 Everlywell Recent Developments
- 6.8 Oxford Immunotec Global PLC(PerkinElmer)
- 6.8.1 Oxford Immunotec Global PLC(PerkinElmer) Company Information
- 6.8.2 Oxford Immunotec Global PLC(PerkinElmer) Business Overview
- 6.8.3 Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Testing Product Portfolio
- 6.8.5 Oxford Immunotec Global PLC(PerkinElmer) Recent Developments
- 6.9 BioMerieux
- 6.9.1 BioMerieux Company Information
- 6.9.2 BioMerieux Business Overview
- 6.9.3 BioMerieux Lyme Disease Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 BioMerieux Lyme Disease Testing Product Portfolio
- 6.9.5 BioMerieux Recent Developments
- 6.10 Bio-Rad Laboratories
- 6.10.1 Bio-Rad Laboratories Company Information
- 6.10.2 Bio-Rad Laboratories Business Overview
- 6.10.3 Bio-Rad Laboratories Lyme Disease Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Bio-Rad Laboratories Lyme Disease Testing Product Portfolio
- 6.10.5 Bio-Rad Laboratories Recent Developments
- 6.11 T2 Biosystems
- 6.11.1 T2 Biosystems Company Information
- 6.11.2 T2 Biosystems Business Overview
- 6.11.3 T2 Biosystems Lyme Disease Testing Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 T2 Biosystems Lyme Disease Testing Product Portfolio
- 6.11.5 T2 Biosystems Recent Developments
7 North America
- 7.1 North America Lyme Disease Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Lyme Disease Testing Market Size by Country (2021-2026)
- 7.3 North America Lyme Disease Testing Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Lyme Disease Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Lyme Disease Testing Market Size by Country (2021-2026)
- 8.3 Europe Lyme Disease Testing Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Lyme Disease Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Lyme Disease Testing Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Lyme Disease Testing Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Lyme Disease Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Lyme Disease Testing Market Size by Country (2021-2026)
- 10.3 South America Lyme Disease Testing Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Lyme Disease Testing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Lyme Disease Testing Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Lyme Disease Testing Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst